This is a preview of subscription content, log in via an institution to check access.
Notes
2016 US dollars
Reference
Bethea E, et al. Should we treat acute hepatitis C? A decision and cost-effectiveness analysis. Hepatology : 23 Oct 2017. Available from: URL: http://doi.org/10.1002/hep.29611
Rights and permissions
About this article
Cite this article
Immediate DDA therapy cost effective for acute hepatitis C. PharmacoEcon Outcomes News 790, 18 (2017). https://doi.org/10.1007/s40274-017-4463-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-4463-0